Provided by Tiger Trade Technology Pte. Ltd.

Madrigal Pharmaceuticals

511.97
-4.7700-0.92%
Post-market: 512.740.7680+0.15%16:29 EDT
Volume:145.52K
Turnover:74.49M
Market Cap:11.80B
PE:-36.01
High:517.00
Open:515.89
Low:507.18
Close:516.74
52wk High:615.00
52wk Low:393.61
Shares:23.06M
Float Shares:13.73M
Volume Ratio:0.55
T/O Rate:1.06%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-14.2164
EPS(LYR):-12.8501
ROE:-53.31%
ROA:-17.84%
PB:22.54
PE(LYR):-39.84

Loading ...

Oct 31, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 31, 2024

Major Issues Report

Form 8-K - Current report
Sep 10, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 07, 2024

Major Issues Report

Form 8-K - Current report
Aug 07, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 27, 2024

Major Issues Report

Form 8-K - Current report
Jun 14, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 14, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 14, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 13, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 07, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 15, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 07, 2024

Major Issues Report

Form 8-K - Current report
May 07, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 07, 2024

Major Issues Report

Form 8-K - Current report
Apr 04, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 04, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 02, 2024

Major Issues Report

Form 8-K - Current report
Apr 02, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities